“A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD”, JOC, vol. 24, no. 8s, pp. 542–546, Oct. 2025, doi: 10.64149/J.Carcinog.24.8s.542-546.